These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34396370)

  • 21. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation.
    Jamieson CH; Gotlib J; Durocher JA; Chao MP; Mariappan MR; Lay M; Jones C; Zehnder JL; Lilleberg SL; Weissman IL
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6224-9. PubMed ID: 16603627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MAPK-negative feedback regulation confers dependence to JAK2
    Kesarwani M; Kincaid Z; Azhar M; Menke J; Schwieterman J; Ansari S; Reaves A; Deininger ME; Levine R; Grimes HL; Azam M
    Leukemia; 2023 Aug; 37(8):1686-1697. PubMed ID: 37430058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human DC3 Antigen Presenting Dendritic Cells From Induced Pluripotent Stem Cells.
    Satoh T; Toledo MAS; Boehnke J; Olschok K; Flosdorf N; Götz K; Küstermann C; Sontag S; Seré K; Koschmieder S; Brümmendorf TH; Chatain N; Tagawa YI; Zenke M
    Front Cell Dev Biol; 2021; 9():667304. PubMed ID: 34368123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A gain-of-function mutation of JAK2 in myeloproliferative disorders.
    Kralovics R; Passamonti F; Buser AS; Teo SS; Tiedt R; Passweg JR; Tichelli A; Cazzola M; Skoda RC
    N Engl J Med; 2005 Apr; 352(17):1779-90. PubMed ID: 15858187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JAK2 V617F mutation prevalence in myeloproliferative neoplasms in Pernambuco, Brazil.
    da Silva RR; Domingues Hatzlhofer BL; Machado CG; Lima AS; de Albuquerque DM; dos Santos MN; Fertrin KY; Costa FF; Araújo Ada S; Bezerra MA
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):802-5. PubMed ID: 22304488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2-V617F mouse model of MPN.
    Grisouard J; Shimizu T; Duek A; Kubovcakova L; Hao-Shen H; Dirnhofer S; Skoda RC
    Blood; 2015 Mar; 125(13):2131-40. PubMed ID: 25595737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The impact of autophagy on proliferation of HEL cells and hematopoietic cells of polycythemia vera patients with JAK2 V617F mutation].
    Dong L; Shen X; Wei W; Shi W; Zhang G; Cao W; Li D
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):520-5. PubMed ID: 26134021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia.
    Li J; Spensberger D; Ahn JS; Anand S; Beer PA; Ghevaert C; Chen E; Forrai A; Scott LM; Ferreira R; Campbell PJ; Watson SP; Liu P; Erber WN; Huntly BJ; Ottersbach K; Green AR
    Blood; 2010 Sep; 116(9):1528-38. PubMed ID: 20489053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JAK2 exon 14 skipping in patients with primary myelofibrosis: a minor splice variant modulated by the JAK2-V617F allele burden.
    Catarsi P; Rosti V; Morreale G; Poletto V; Villani L; Bertorelli R; Pedrazzini M; Zorzetto M; Barosi G;
    PLoS One; 2015; 10(1):e0116636. PubMed ID: 25617626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STAT5 activation is critical for the transformation mediated by myeloproliferative disorder-associated JAK2 V617F mutant.
    Funakoshi-Tago M; Tago K; Abe M; Sonoda Y; Kasahara T
    J Biol Chem; 2010 Feb; 285(8):5296-307. PubMed ID: 20028972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Megakaryopoiesis and platelet function in polycythemia vera and essential thrombocythemia patients with JAK2 V617F mutation.
    Hattori N; Fukuchi K; Nakashima H; Maeda T; Adachi D; Saito B; Yanagisawa K; Matsuda I; Nakamaki T; Gomi K; Tomoyasu S
    Int J Hematol; 2008 Sep; 88(2):181-188. PubMed ID: 18612778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression.
    Marty C; Lacout C; Droin N; Le Couédic JP; Ribrag V; Solary E; Vainchenker W; Villeval JL; Plo I
    Leukemia; 2013 Nov; 27(11):2187-95. PubMed ID: 23558526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.
    Fleischman AG; Aichberger KJ; Luty SB; Bumm TG; Petersen CL; Doratotaj S; Vasudevan KB; LaTocha DH; Yang F; Press RD; Loriaux MM; Pahl HL; Silver RT; Agarwal A; O'Hare T; Druker BJ; Bagby GC; Deininger MW
    Blood; 2011 Dec; 118(24):6392-8. PubMed ID: 21860020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F.
    Lundberg P; Takizawa H; Kubovcakova L; Guo G; Hao-Shen H; Dirnhofer S; Orkin SH; Manz MG; Skoda RC
    J Exp Med; 2014 Oct; 211(11):2213-30. PubMed ID: 25288396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X chromosome inactivation analysis reveals a difference in the biology of ET patients with JAK2 and CALR mutations.
    Allen C; Lambert JR; Linch DC; Gale RE
    Blood; 2014 Sep; 124(13):2091-3. PubMed ID: 25139350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HDAC inhibitor Givinostat modulates the hematopoietic transcription factors NFE2 and C-MYB in JAK2(V617F) myeloproliferative neoplasm cells.
    Amaru Calzada A; Todoerti K; Donadoni L; Pellicioli A; Tuana G; Gatta R; Neri A; Finazzi G; Mantovani R; Rambaldi A; Introna M; Lombardi L; Golay J;
    Exp Hematol; 2012 Aug; 40(8):634-45.e10. PubMed ID: 22579713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils.
    Kimishima Y; Misaka T; Yokokawa T; Wada K; Ueda K; Sugimoto K; Minakawa K; Nakazato K; Ishida T; Oshima M; Koide S; Shide K; Shimoda K; Iwama A; Ikeda K; Takeishi Y
    Nat Commun; 2021 Oct; 12(1):6177. PubMed ID: 34702814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenformin increases early hematopoietic progenitors in the Jak2
    Alves-Silva AB; Fenerich BA; Fonseca NP; Fernandes JC; Coelho-Silva JL; Pereira-Martins DA; Bianco TM; Scheucher PS; Rego EM; Chahud F; Machado-Neto JA; Figueiredo-Pontes LL; Traina F
    Invest New Drugs; 2022 Jun; 40(3):576-585. PubMed ID: 35015172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cigarette smoke stimulates clonal expansion of Jak2
    Ramanathan G; Chen JH; Mehrotra N; Trieu T; Huang A; Mas E; Monterrosa Mena JE; Bliss B; Herman DA; Kleinman MT; Fleischman AG
    Front Oncol; 2023; 13():1210528. PubMed ID: 37546389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New Murine Model of Clonal Hematopoiesis Investigates
    Patel AP; Natarajan P
    JACC Basic Transl Sci; 2019 Oct; 4(6):698-700. PubMed ID: 31713537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.